Arrhythmia Research Technology, Inc.  

(Public, NYSEMKT:HRT)   Watch this stock  
Find more results for NYSEAMEX:HRT
7.58
-0.02 (-0.26%)
Feb 27 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 7.39 - 7.63
52 week 4.46 - 8.00
Open 7.40
Vol / Avg. 0.00/3,700.00
Mkt cap 20.90M
P/E 39.08
Div/yield     -
EPS 0.19
Shares 2.76M
Beta 1.34
Inst. own 13%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 2.14% -16.49%
Operating margin 3.31% -4.49%
EBITD margin - 2.28%
Return on average assets 3.31% -21.13%
Return on average equity 7.41% -43.87%
Employees 98 -
CDP Score - -

Address

25 Sawyer Passway
FITCHBURG, MA 01420
United States - Map
+1-978-3455000 (Phone)
+1-978-3420168 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Arrhythmia Research Technology, Inc. (ART) manufactures components, devices and equipment for medical, military, law enforcement, industrial and automotive applications. The Company is engaged in the production and sale of silver/silver chloride coated and conductive resin sensors used as component parts in the manufacture of integrated disposable electrophysiological sensors. The Company also performs custom thermoplastic injection molding and provides a full array of design, engineering and production services and management. The Company's orthopedic implant machining operation produces quick-turn, high volume and patient-specific, finished orthopedic implants. In addition to its manufacturing capabilities, the Company, through its Predictor brand, also licenses proprietary customizable signal-averaging electrocardiography (SAECG) software used to help assess a patient's risk of certain heart arrhythmias.

Officers and directors

E. P. Marinos Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Salvatore Emma Jr. President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Derek T. Welch Chief Financial Officer
Bio & Compensation  - Reuters
Jason R. Chambers Independent Director
Age: 36
Bio & Compensation  - Reuters
Paul F. Walter M.D. Independent Director
Age: 77
Bio & Compensation  - Reuters